title: Development of parkinsonism after transient ischemic attacks.
abstract: In order to correlate the influence of cerebrovascular disorders with the appearance of parkinsonism, 115 patients aged between 32 and 84 years (mean = 65) with transient ischemic attacks were followed up for one year. They were treated with platelet antiaggregant drugs. None of them received neuroleptics, calcium antagonists or other drugs known to induce parkinsonism. During the study, 8 patients (mean = 75 years) developed parkinsonism, bilateral in all but one, who remarkably enough was the only case responding to L-dopa treatment. On comparing recorded with expected incidence, our series showed significantly greater values. Our findings suggest that cerebrovascular disorders are factors contributing to parkinsonism in the elderly.
authors.forename: E
authors.initials: E
authors.lastname: Herskovits
authors.forename: F
authors.initials: F
authors.lastname: Micheli
authors.forename: M
authors.initials: M
authors.lastname: Fernández Pardal
authors.forename: R
authors.initials: R
authors.lastname: Domínguez
authors.forename: L
authors.initials: L
authors.lastname: Tamaroff
authors.forename: A
authors.initials: A
authors.lastname: Famulari
authors.forename: A
authors.initials: A
authors.lastname: Scarlatti
authors.forename: V
authors.initials: V
authors.lastname: Rocchi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000188:drug therapy / Q000209:etiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors